; (2) to provide recommendations for improving detection of fentanyl-related overdose outbreaks; and (3) to encourage States to expand access to, and training on, naloxone; Whereas, in August 2016, the Centers for Disease Control and Prevention updated the health advisory issued in October 2015 to make public health officials aware of the increasing— (1) availability of counterfeit pills containing various amounts of fentanyl and fentanyl-related compounds; and (2) frequency with which fentanyl-related compounds are mixed with, or sold as, heroin; Whereas illicit fentanyl has the potential to endanger public health workers, first responders, and law enforcement personnel who may unwittingly come into contact with illicit fentanyl by accidentally inhaling airborne powder; Whereas, according to the DEA— (1) Mexico is the primary source for illicit fentanyl trafficked into the United States; and (2) distributors in China are the source of the fentanyl analogs and the precursor chemicals to manufacture fentanyl analogs that are found in Mexico and Canada; Whereas fentanyl produced illicitly in Mexico is— (1) smuggled across the southwest border of the United States, or delivered through mail and express consignment couriers; and (2) often mixed with heroin or diluents in the United States and then distributed in the same United States markets in which white powder heroin is distributed; and Whereas United States law enforcement officials have recently seen— (1) an influx of illicit fentanyl into the United States directly from China; (2) shipments of the equipment to manufacture illicit fentanyl, such as pill presses; and (3) some illicit fentanyl products being smuggled into the United States across the northern border with Canada: Now, therefore, be it